Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0001 USD | +9.900,00% | -.--% | -66,67% |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2020 | Gewicht | 2021 | Gewicht | Delta |
---|---|---|---|---|---|
Clinic Testing
92,6
%
| 1 | 20,5 % | 22 | 92,6 % | +4.049,80% |
Cannaboid Products
3,8
%
| 2 | 64,5 % | 1 | 3,8 % | -45,40% |
Wholesale
2,4
%
| 0 | 2,2 % | 1 | 2,4 % | +883,77% |
Cannaboid Testing
1,2
%
| 0 | 12,8 % | 0 | 1,2 % | -16,19% |
Verkoop per regio
USD in miljoen | 2020 | Gewicht | 2021 | Gewicht | Delta |
---|---|---|---|---|---|
United Kingdom
100,0
%
| 3 | 100,0 % | 23 | 100,0 % | +817,37% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
George Thomas
CEO | Chief Executive Officer | 35 | 26-01-21 |
Geremy Thomas
FOU | Founder | 64 | 14-02-11 |
John Pettit
CTO | Chief Tech/Sci/R&D Officer | - | - |
Emily Critchley
HRO | Human Resources Officer | - | - |
Paul van Issum
PRN | Corporate Officer/Principal | - | - |
Anne Tew
SEC | Corporate Secretary | - | 01-11-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Geremy Thomas
FOU | Founder | 64 | 14-02-11 |
George Thomas
CEO | Chief Executive Officer | 35 | 26-01-21 |
Anne Tew
SEC | Corporate Secretary | - | 01-11-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 364 962 760 | 256 430 105 ( 70,26 %) | 0 | 70,26 % |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Sativa Group Plc
Sativa Group Plc Financial ConglomeratesFinance Sativa Group Plc engages in the production, testing and compliance, commercialization, sales, and marketing of cannabidiol products. It operates through the following segments: Products; Testing; and Extraction and Research and Development. The Products segment focuses in the sale of cannabidiol products. The Testing segment involves in testing cannabidiol products. The Extraction and Research and Development segment include extraction and research and development operations which develops future products. The company was founded by Geremy Howard Prance Thomas on December 19, 2017 and is headquartered in London, the United Kingdom. |
Financial Conglomerates
|
Sector
Verkoop per activiteit
Chiffre d''affaires - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-66,67% | 3,65K | |
+42,38% | 6,28 mld. | |
-15,86% | 4,51 mld. | |
+6,36% | 3,35 mld. | |
-11,28% | 3,13 mld. | |
-3,23% | 2,47 mld. | |
+45,24% | 1,96 mld. | |
-7,89% | 1,68 mld. | |
-0,98% | 1,63 mld. | |
-11,32% | 1,56 mld. |
- Beurs
- Aandelen
- Koers GDBYF
- Onderneming Goodbody Health Limited